Skip to main content Deutsch

News

ÖAW DOC Fellowship für Namrata Singh

Medicine & Science, People of the MedUni Vienna

Namrata Singh, PhD candidate in the lab of Dr. Juliane Winkler, was awarded the doctoral fellowship program (DOC) of the Austrian Academy of Sciences…

Thomas Vogl receives "Global Grant for Gut Health"

University, Medicine & Science, People of the MedUni Vienna

Thomas Vogl's research team at MedUni Vienna's Center for Cancer Research aims to identify biomarkers in the gut microbiome that are associated with…

Basic research: Inhibition of epigenetic control enzymes in immune cells as a potential new starting point in cancer immunotherapy

Medicine & Science

Immunotherapy is one of the pillars in the fight against cancer and aims to enable the body's own immune system to fight a tumor. A recent study now…

Open day / donor day 2024

Medicine & Science, People of the MedUni Vienna, Organisation

On May 24, 2024, you can experience first hand how we work with living cancer cells in the laboratory and much more.

Join us on a journey to the…

Long Night of Research 2024 - Stations focusing on "Cancer Research and Oncology"

University, Medicine & Science, Organisation

The experts from “Mission Cancer” are waiting at Borschkegasse 4 (Walter-Beck-Platz). They offer insights into their laboratories and provide numerous…

Thomas Bauer receives a Principal Investigator project from the Austrian Science Fund FWF

Medicine & Science, People of the MedUni Vienna

Thomas Bauer's research project "Defense Mechanisms during Microbial Hair Follicle Invasion" was approved for funding by the Austrian Science Fund…

Possible trigger of chronic inflammatory bowel disease identified

Medicine & Science

As the cause of chronic inflammatory bowel diseases (IBD) such as Crohn's disease or ulcerative colitis is not yet known, treatment for sufferers is…

Juliane Winkler successful in WWTF Life Sciences 2023 call "Understanding Biology with AI/ML"

Medicine & Science, People of the MedUni Vienna

Juliane Winkler from the Center for Cancer Research was successful with her submission to the Life Sciences 2023 Call "Understanding Biology with…

Pleural mesothelioma: new therapeutic approach to enhance sensitivity to chemo- and radiotherapy

Medicine & Science

Pleural mesothelioma (PM) is mainly caused by asbestos exposure and characterized by poor prognosis and limited therapeutic options.

Europe-wide preclinical test platform for rare tumors in children established and secured for the future

Medicine & Science

The aim is tailored therapies for the most aggressive types of childhood cancer